Previous studies have demonstrated that IFN-γ-primed MSCs show enhanced immune-modulatory abilities in various immune-mediated diseases including EAE [33], atopic dermatitis [35], and multiple sclerosis [39]. The gene discussed is IFNG; the disease is atopic eczema.